Transcranial Magnetic Stimulation (TMS) therapy has demonstrated significant effectiveness as a treatment for various mental health conditions, particularly treatment-resistant depression. Research consistently shows that the
TMS (Transcranial Magnetic Stimulation) shows promise for helping stabilize mood swings in bipolar disorder, particularly during depressive episodes, based on recent research findings. A recent
As Spravato® (esketamine) continues to emerge as a proven and viable mental health treatment, many patients are unaware of what to do after Spravato® treatment.
Transcranial Magnetic Stimulation (TMS) shows promising but mixed results for anxiety treatment. TMS is primarily FDA-approved for depression and certain other conditions like OCD, but
While Spravato® is now an FDA-approved treatment, it is a form of ketamine, making its insurance approval process complicated. So, is Spravato® covered by insurance?
Transcranial Magnetic Stimulation (TMS) is generally well-tolerated, with most side effects being mild and transient. The most common Transcranial Magnetic Stimulation side effects include headaches,
Before beginning your first Spravato® treatment, you may be apprehensive and wondering, what does Spravato® treatment feel like? The medication will be administered as a
Research on Transcranial Magnetic Stimulation (TMS) therapy for Borderline Personality Disorder (BPD) is still emerging, but early findings show promise. The research reports for TMS
As ketamine-assisted therapy gains more acceptance as a viable mental health program, whether patients can use insurance to cover the costs is also a common
Ketamine therapy has shown significant effectiveness in treating treatment-resistant anxiety and PTSD. Unlike traditional antidepressants that work on serotonin, dopamine, or norepinephrine systems, ketamine for
